The expression level of LIM kinase 1 (LIMK1) is closely related to the processing of microRNAs (miRNAs). Studies have shown that LIMK1 expression levels are elevated during the progression of various cancers. Here, researchers investigated the interaction between LIMK1 and miR-106a in oral squamous cell carcinoma (OSCC). They found that miR-106a levels were significantly decreased, while LIMK1 expression was significantly increased in OSCC tissues and cell lines. A strong correlation existed between these changes. Knocking down LIMK1 significantly inhibited OSCC cell proliferation and epithelial-mesenchymal transition (EMT). Bioinformatic analysis predicted that LIMK1 is a potential target gene of miR-106a, and luciferase reporter assays confirmed that miR-106a directly targets LIMK1. Introducing miR-106a into OSCC cells had similar effects to silencing LIMK1. Overexpression of LIMK1 in OSCC cells partially reversed the inhibitory effects caused by miR-106a mimics. These studies suggest that miR-106a inhibits OSCC cell proliferation and EMT by directly reducing LIMK1 expression.
To investigate the function of LIMK1 in oral squamous cell carcinoma (OSCC) cells, researchers constructed LIMK1-knockdown SCC4 cells (Figure 1a). BrdU-ELISA results showed that the proliferation of LIMK1-knockdown SCC4 cells was inhibited (Figure 1b). qRT-PCR results showed that the mRNA levels of PCNA, CDK2, CDK4, cyclin D1, and cyclin E1 were decreased, while the mRNA levels of p21 and p27 were increased in LIMK1-knockdown cells (Figure 1c). Furthermore, LIMK1 knockdown significantly enhanced the expression of the epithelial marker E-cadherin and reduced the expression of the mesenchymal markers N-cadherin and vimentin in SCC4 cells (Figure 1d).
Figure 1. The effects of LIMK1 silencing on the proliferation and EMT in OSCC cells. (Shi B, et al., 2019)